ClearNote Health
Developer of early detection and monitoring tests for multiple forms of cancer.
Technology stack
detected 2026-05-29Company Timeline
What does ClearNote Health do?
ClearNote Health develops DNA-based blood tests for early cancer detection, focusing on cancers with high mortality and limited screening options. Their Avantect® tests and Virtuoso™ epigenomics platform provide early signals of developing cancer by measuring dynamic biological changes from a blood draw. They serve patients at elevated risk for cancers like pancreatic and ovarian cancer, as well as the biopharma industry.
How much funding has ClearNote Health raised?
ClearNote Health has raised a total of $10M in funding. The most recent round on record is Seed.
Where is ClearNote Health headquartered?
ClearNote Health is headquartered in San Diego, California, USA.
When was ClearNote Health founded?
ClearNote Health was founded in 2021.
What industry does ClearNote Health operate in?
ClearNote Health operates in Healthcare, Biotechnology, Diagnostics, Cancer Detection, HealthTech, MedTech.
How many employees does ClearNote Health have?
ClearNote Health has approximately 55 people on record.